|
1
|
Cheng J, Ma S, Yang G, Wang L and Hou W:
The mechanism of computed tomography-guided 125I particle in
treating lung cancer. Med Sci Monit. 23:292–299. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Lin L, Wang J, Jiang Y, Meng N, Tian S,
Yang R, Ran W and Liu C: Interstitial 125I seed implantation for
cervical lymph node recurrence after multimodal treatment of
thoracic esophageal squamous cell carcinoma. Technol Cancer Res
Treat. 14:201–207. 2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Gaopeng L, Shengli D, Ye LU, Miaoyun L,
Jian G and Qibin T: The cooperative effect of p53 and Rb in local
nanotherapy in a rabbit VX2 model of hepatocellular carcinoma. Int
J Nanomedicine. 8:3757–3768. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Leth T, Von Oettingen G, Lassen-Ramshad
YA, Lukacova S and HøYer M: Survival and prognostic factors in
patients treated with stereotactic radiotherapy for brain
metastases. Acta Oncologica. 54:107–114. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Quintás-Cardama A, Daver N, Kim H, Dinardo
C, Jabbour E, Kadia T, Borthakur G, Pierce S, Shan J,
Cardenas-Turanzas M, et al: A prognostic model of therapy-related
myelodysplastic syndrome for predicting survival and transformation
to acute myeloid leukemia. Clin Lymphoma Myeloma Leukemia.
14:401–410. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Třeška V, Duras P, Mírka H, Skalický T and
Sutnar A: [Chemoembolization with Drug Eluting Beads (TACE DEB) in
patients with primary unresectable hepatocellular carcinoma (HCC)].
Rozhledy v chirurgii: měsíník eskoslovenské chirurgické spolenosti.
93:63–69. 2014.PubMed/NCBI
|
|
7
|
Hutchings M: FDG-PET response-adapted
therapy: Is 18F-fluorodeoxyglucose positron emission tomography a
safe predictor for a change of therapy? Hematol Oncol Clin North
Am. 28:87–103. 2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lim AJ, Brandon AH, Fiedler J, Brickman
AL, Boyer CI, Raub WA Jr and Soloway MS: Quality of life: Radical
prostatectomy versus radiation therapy for prostate cancer. J Urol.
154:1420–1425. 1995.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Gao F, Li C, Gu Y, Huang J and Wu P:
CT-guided 125I brachytherapy for mediastinal metastatic lymph nodes
recurrence from esophageal carcinoma: Effectiveness and safety in
16 patients. Eur J Radiol. 82:e70–e75. 2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Nakamura R, Kikuchi K, Tanji S, Yabuuchi
T, Uwano I, Yamaguchi S, Ariga H and Fujioka T: Narrow safety range
of intraoperative rectal irradiation exposure volume for avoiding
bleeding after seed implant brachytherapy. Radiat Oncol.
7(15)2012.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhang F, Wu K, Gao F, Zhang W, Shi F and
Li C: Refractory nasopharyngeal carcinoma: Positron emission
tomography combined with computed tomography-guided 125I seed
implantation therapy after repeated traditional radiochemotherapy.
Otolaryngol Head Neck Surg. 149:417–423. 2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Li C, Yao L, Gong J, Pang H, Shan Q and
Wang Z, Lu J and Wang Z: Efficacy of gefitinib combined with
125I radioactive particles in the treatment of
transplanted lung cancer tumors in nude mice. Cardiovasc Intervent
Radiol. 43:1364–1370. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Toba H, Sakiyama S, Otsuka H, Kawakami Y,
Takizawa H, Kenzaki K, Kondo K and Tangoku A:
18F-fluorodeoxyglucose positron emission tomography/computed
tomography is useful in postoperative follow-up of asymptomatic
non-small-cell lung cancer patients. Interact Cardiovasc Thorac
Surg. 15:859–864. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zou JF: Effect of 125I radioactive
particle implantation combined with TACE treatment on serum markers
apoptotic molecules in tumor tissue of patients with primary
hepatocellular carcinoma. J Hainan Medical University. 22:101–104.
2016.
|
|
15
|
Lu KV, Chang JP, Parachoniak CA, Pandika
MM, Aghi MK, Meyronet D, Isachenko N, Fouse SD, Phillips JJ,
Cheresh DA, et al: VEGF inhibits tumor cell invasion and
mesenchymal transition through a MET/VEGFR2 complex. Cancer Cell.
22:21–35. 2012.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Aggarwal S, Devaraja K, Sharma SC and Das
SN: Expression of vascular endothelial growth factor (VEGF) in
patients with oral squamous cell carcinoma and its clinical
significance. Clinica Chimica Acta. 436:35–40. 2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Li M, Wang Z, Xing Y, Yu J, Tian L, Zhang
D and Xin Z: A multicenter study on expressions of vascular
endothelial growth factor, matrix metallopeptidase-9 and tissue
inhibitor of metalloproteinase-2 in oral and maxillofacial squamous
cell carcinoma. Iran Red Crescent Med J. 16(e13185)2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Diaz-Rubio E, Gomez-Espana A, Massuti B,
Sastre J, Abad A, Valladares M, Rivera F, Safont MJ, Martínez de
Prado P, Gallén M, et al: First-line XELOX plus bevacizumab
followed by XELOX plus bevacizumab or single-agent bevacizumab as
maintenance therapy in patients with metastatic colorectal cancer:
The phase III MACRO TTD study. Oncologist. 17:15–25.
2012.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Verma A, Um SW, Koh WJ, Suh GY, Chung MP,
Kwon OJ and Kim H: Long-term tolerance of airway silicone stent in
patients with post-tuberculosis tracheobronchial stenosis. ASAIO J.
58:530–534. 2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Dedic-Hagan J, Teh AY, Liang E, Collett N
and Woo HH: Migration of a strand of four seeds in low-dose-rate
brachytherapy. BMJ Case Rep: May 30, 2014 (Epub ahead of print).
doi: 10.1136/bcr-2014-204515.
|
|
21
|
Shin DY, Han SW, Oh DY, Im SA, Kim TY and
Bang YJ: Prognostic implication of (18)F FDG-PET in patients with
extrahepatic metastatic hepatocellular carcinoma undergoing
systemic treatment, a retrospective cohort study. Cancer Chemother
Pharmacol. 68:165–175. 2011.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Salem R, Gordon AC, Mouli S, Hickey R,
Kallini J, Gabr A, Mulcahy MF, Baker T, Abecassis M, Miller FH, et
al: Y90 radioembolization significantly prolongs time to
progression compared with chemoembolization in patients with
hepatocellular carcinoma. Gastroenterology. 151:1155–1163.e2.
2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Assi R, Kantarjian H, Ravandi F and Daver
N: Immune therapies in acute myeloid leukemia: A focus on
monoclonal antibodies and immune checkpoint inhibitors. Curr Opin
Hematol. 25:136–145. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Caresia Aroztegui AP, Garcia Vicente AM,
Alvarez Ruiz S, Delgado Bolton RC, Orcajo Rincon J, Garcia Garzon
JR, de Arcocha Torres M and Garcia-Velloso MJ: Oncology Task Force
of the Spanish Society of Nuclear Medicine and Molecular Imaging:
18F-FDG PET/CT in breast cancer: Evidence-based recommendations in
initial staging. Tumour Biol: Oct 12, 2017 (Epub ahead of print).
doi: 10.1177/1010428317728285.
|
|
25
|
Dietlein M, Klussmann JP and Drzezga A:
18F-FDG PET/CT in head and neck tumors. Nuklearmedizin. 59:8–11.
2020.PubMed/NCBI View Article : Google Scholar : (In German).
|
|
26
|
Wang H, Peng R, Li X, Wang Y, Jiang Y, Ji
Z, Guo F, Tian S, Sun H, Fan J and Wang J: The dosimetry evaluation
of 3D printing non-coplanar template-assisted CT-guided 125I seed
stereotactic ablation brachytherapy for pelvic recurrent rectal
cancer after external beam radiotherapy. J Radiat Res. 62:473–482.
2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Qu A, Jiang P, Wei S, Jiang Y, Ji Z, Sun
H, Li W, Shao Y, Fan J and Wang J: Accuracy and dosimetric
parameters comparison of 3D-printed non-coplanar template-assisted
computed tomography-guided iodine-125 seed ablative brachytherapy
in pelvic lateral recurrence of gynecological carcinomas. J Contemp
Brachytherapy. 13:39–45. 2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Li J, Wang J, Meng N, Qu A, Yuan H, Liu C,
Ran W and Jiang Y: Image-guided percutaneous (125)I seed
implantation as a salvage treatment for recurrent soft tissue
sarcomas after surgery and radiotherapy. Cancer Biother Radiopharm.
26:113–120. 2011.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wang W, Qin H, Zhu X, et al: The study of
different activity ~(125)I seeds implantation to therapy rabbit
liver VX2 tumor. Journal of Anhui Medical University. 50:778–781.
2015.(In Chinese).
|
|
30
|
Bradley JD, Paulus R, Komaki R, Masters G,
Blumenschein G, Schild S, Bogart J, Hu C, Forster K, Magliocco A,
et al: Standard-dose versus high-dose conformal radiotherapy with
concurrent and consolidation carboplatin plus paclitaxel with and
without cetuximab for patients with stage IIIA and IIIB
non-small-cell lung cancer (RTOG 0617): A randomized, two-by-two
factorial phase 3 study. Lancet Oncol. 16:187–199. 2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Pan D, Yang M, Xu Y, Wang L, Liu L and
Huang P: Experimental study of CT guided ³²P-CP-PLLA microparticle
implantation in the treatment of rabbit VX2 lung tumor. Zhongguo
Fei Ai Za Zhi. 14:1–6. 2011.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
32
|
He X, Liu M, Zhang M, Sequeiros RB, Xu Y,
Wang L, Liu C, Wang Q, Zhang K and Li C: A novel three-dimensional
template combined with MR-guided (125)I brachytherapy for recurrent
glioblastoma. Radiat Oncol. 15(146)2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Li CC, Chi JL, Ma Y, Li JH, Xia CQ, Li L,
Chen Z and Chen XL: Interventional therapy for human breast cancer
in nude mice with 131I gelatin microspheres (¹³¹I-GMSs) following
intratumoral injection. Radiat Oncol. 9(144)2014.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Zhao GS, Liu S, Yang L, Li C, Wang RY,
Zhou J and Zhang YW: Evaluation of radioactive (125)I seed
implantation for the treatment of refractory malignant tumours
based on a CT-guided 3D template-assisted technique: Efficacy and
safety. BMC Cancer. 20(718)2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Yao LH, Su L, Liu L, Sun HT and Wang JJ:
Stenting of the portal vein combined with different numbers of
Iodine-125 seed strands: Dosimetric analyses. Chin Med J (Engl).
130:2183–2189. 2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Huo X, Huo B, Wang H, Wang L, Cao Q, Zheng
G, Wang J, Chai S, Zhang Z, Yang K, et al: Implantation of computed
tomography-guided Iodine-125 seeds in combination with chemotherapy
for the treatment of stage III non-small cell lung cancer. J
Contemp Brachytherapy. 9:527–534. 2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Yang Z, Zhang Y, Xu D, Maccauro G, Rossi
B, Jiang H, Wang J, Sun H, Xu L, Chen Y and Liu X: Percutaneous
vertebroplasty combined with interstitial implantation of 125I
seeds in banna mini-pigs. World J Surg Oncol. 11(46)2013.PubMed/NCBI View Article : Google Scholar
|
